Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Simultaneous Determination of Ciprofloxacin Hydrochloride and Dexamethasone in Ophthalmic Solution by Reversed Phase High Performance Liquid Chromatography


Affiliations
1 D. G. Ruparel College, Matunga, Mumbai-400016, India
     

   Subscribe/Renew Journal


A gradient reverse phase HPLC method was developed and validated for simultaneous estimation of ciprofloxacin hydrochloride and dexamethasone in pharmaceutical dosage form i.e. ophthalmic solution using Nucleosil C18 (15 cm×4.6 mm, 5 μm) column with a flow rate of 1.2 ml/minute and detection of 265 nm. The mobile phase A consisted of 50 milli molar citric acid and potassium phosphate buffer. The mobile phase B consisted of 100% v/v acetonitrile. The method was validated for system suitability, linearity, accuracy and precision. The system suitability parameters like resolution, theoretical plates and tailing factor were evaluated. The linear range for ciprofloxacin was 3 μg/ml-55 μg/ml and for dexamethasone was 1 μg/ml-16 μg/ml. The method has been successfully used to analyze pharmaceutical dosage form i.e. ophthalmic solution containing ciprofloxacin hydrochloride and dexamethasone with good recoveries.

Keywords

Ciprofloxacin Hydrochloride, Dexamethasone, Pharmaceutical Dosage Form.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 155

PDF Views: 0




  • Simultaneous Determination of Ciprofloxacin Hydrochloride and Dexamethasone in Ophthalmic Solution by Reversed Phase High Performance Liquid Chromatography

Abstract Views: 155  |  PDF Views: 0

Authors

R. V. Rele
D. G. Ruparel College, Matunga, Mumbai-400016, India
C. B. Warkar
D. G. Ruparel College, Matunga, Mumbai-400016, India

Abstract


A gradient reverse phase HPLC method was developed and validated for simultaneous estimation of ciprofloxacin hydrochloride and dexamethasone in pharmaceutical dosage form i.e. ophthalmic solution using Nucleosil C18 (15 cm×4.6 mm, 5 μm) column with a flow rate of 1.2 ml/minute and detection of 265 nm. The mobile phase A consisted of 50 milli molar citric acid and potassium phosphate buffer. The mobile phase B consisted of 100% v/v acetonitrile. The method was validated for system suitability, linearity, accuracy and precision. The system suitability parameters like resolution, theoretical plates and tailing factor were evaluated. The linear range for ciprofloxacin was 3 μg/ml-55 μg/ml and for dexamethasone was 1 μg/ml-16 μg/ml. The method has been successfully used to analyze pharmaceutical dosage form i.e. ophthalmic solution containing ciprofloxacin hydrochloride and dexamethasone with good recoveries.

Keywords


Ciprofloxacin Hydrochloride, Dexamethasone, Pharmaceutical Dosage Form.